{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "Dealbook", "document_type": "blogpost", "multimedia": [], "abstract": "Shire agrees to buy NPS Pharmaceuticals for $5.2 billion. | Banks brace for a jolt as the price of oil falls. | Kicking Dodd-Frank in the teeth. | David A. O\u2019Neil, a federal prosecutor, is joining the law firm Debevoise & Plimpton.", "type_of_material": "Blog", "word_count": "0", "lead_paragraph": null, "pub_date": "2015-01-12T07:31:57Z", "_id": "54b3bf5038f0d82eb90f1bbd", "byline": {"original": "By SYDNEY EMBER", "person": [{"rank": 1, "role": "reported", "firstname": "Sydney", "organization": "", "lastname": "EMBER"}]}, "source": "The New York Times", "snippet": "Shire agrees to buy NPS Pharmaceuticals for $5.2 billion. | Banks brace for a jolt as the price of oil falls. | Kicking Dodd-Frank in the teeth. | David A. O\u2019Neil, a federal prosecutor, is joining the law firm Debevoise & Plimpton.", "web_url": "http://dealbook.nytimes.com/2015/01/12/morning-agenda-shires-deal-for-nps/", "slideshow_credits": null, "blog": [], "keywords": [], "headline": {"main": "Morning Agenda: Shire's Deal for NPS", "kicker": "DealBook"}}